A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Clinical trial NCT06862219 · RECRUITING

Trial details

NCT number: NCT06862219
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma

Start date: 2025-06-21
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.